Carbenicillin indanyl sodium, an orally active derivative of carbenicillin, is active against a broad spectrum of bacterial species. Although the ester has in vitro antimicrobial activity per se when evaluated in Brain Heart Infusion broth, the in vivo antibacterial activity seen in mice and rats reflects primarily the efficient hydrolysis of the ester to carbenicillin. With an acute systemic infection in mice as a test system, orally administered carbenicillin indanyl sodium protected mice against lethal infections produced by Escherichia coli, Salmonella choleraesuis, Pasteurella multocida, Proteus vulgaris, Staphylococcus aureus, and Streptococcus pyogenes. The dose that protected 50% of the animals against each of these infections was comparable to that of parenteral carbenicillin. Against experimental urinary-tract disease in rats produced by E. coli, P. vulgaris, and Pseudomonas aeruginosa, it was again observed that carbenicillin indanyl sodium provided activity comparable to that of parenterallv administered carbenicillin.
Because of its unique activity against Pseudomonas aeruginosa and indole-positive Proteus species usually resistant to ampicillin, carbenicillin has assumed an important role as a parenteral chemotherapeutic agent for the serious medical problems caused by these microorganisms. Carbenicillin is administered parenterally as disodium carbenicillin. This formulation is, however, poorly absorbed or acid-labile, or both, when given orally and is not therapeutically effective. The 5-indanyl ester of carbenicillin ( Fig. 1) is an acid-stable form of carbenicillin. It is well absorbed from the gastrointestinal tract and is rapidly hydrolyzed in vivo to carbenicillin. Laboratory studies presented in this report demonstrate that the ester provides bacteriological activity comparable to that of parenterally administered carbenicillin.
MATERIALS AND METHODS Antibiotics. Carbenicillin indanyl sodium was used as the crystalline monosodium salt; carbenicillin, as the amorphous disodium salt. When appropriate, ampicillin and cephalexin were used in comparative studies. Ampicillin was used as the trihydrate and cephalexin as the monohydrate. The latter two compounds were provided by, respectively, the Biological Division of Bristol Laboratories, Syracuse, N.Y., and Eli Lilly & Co., Indianapolis, Ind.
The hydrolysis of carbenicillin indanyl sodium to carbenicillin after oral administration to animals was readily demonstrated through the use of a descending paper chromatographic system. The solvent system contained n-butanol, water, ether, and acetone in a ratio of 3:1:1:1. Serum and urine samples collected at appropriate times after carbenicillin indanyl sodium dosage were spotted on chromatographic paper strips (Whatman no. 4) which were then developed in the solvent system for 1 hr at room temperature. After drying, the strips were placed onto the surface of bio- (10) and Edwards and Park (4). Radioactivity was counted as described previously (9) .
In vitro acid stability studies. Carbenicillin indanyl sodium was added to synthetic gastric juice (pH 2.0) at 400 or 800 Ag/ml, and the solution was maintained at 37 C for 1 hr. A 0.5-ml portion was serially diluted in BHI broth through 10 In vivo studies. Acute systemic infections in mice were produced by intraperitoneal inoculation of standardized cultures suspended in 5% hog gastric mucin. The severity of infection was consistently at 1 to 10 LDloo, i.e., 1 to 10 times the number of organisms needed to kill 100% of the mice. Treatment with test antibiotics was initiated 0.5 hr after challenge, and a second dose was administered 4 hr later. After a holding period of 4 days, living mice were counted, and the per cent survivors was calculated. These values were then converted to probits, and a PDss value in milligrams per kilogram was calculated by means of a probit method (1) . The PD50 is defined as the dose of antibiotic in milligrams per kilogram required to protect 50% of the treated mice against the otherwise lethal infection.
Experimental infections were produced in rats to assess the therapeutic potential of carbenicillin indanyl sodium against urinary-tract disease. The details of the technique as used in this laboratory for Proteus vulgaris and Pselidomontas aeruginosa have been published previously (7) . Experimental infections with E. coli 028 utilized the urether ligation technique followed by intravenous administration of the organism (8) . In all instances, rats were dosed once a day for 8 days, with the first dose being administered the day after infection. Rats were killed 24 hr after the last dose, kidneys were removed and macerated, and viable counts of organisms were made on appropriate media. Such counts are expressed as log averages, and efficacy is measured on the basis of a reduction in log counts compared with infected controls.
RESULTS AND DISCUSSIONS
The indanyl ester of carbenicillin provides chemical stability which prevents degradation by gastric juice and, in addition, contributes the lipophilic properties necessary for good absorption from the gastrointestinal tract. The indanyl moiety plays a temporary role only, as it is rapidly removed in vivo to regenerate the active parent compound, i.e., carbenicillin. Biological activity in vivo is due to a preponderance of carbenicillin, as only trace amounts (0.1 to 1.0 ,ug/ml) of carbenicillin indanyl sodium have been detected in serum (3) . Indanyl carbenicillin Table  2 . Carbenicillin indanyl sodium competes for 4C-penicillin G binding sites on S. aureus (Oxford strain) better than either carbenicillin or ampicillin but not benzylpenicillin or phenoxymethylpenicillin. It appears that the ester moiety of carbenicillin indanyl sodium facilitates binding in comparison with either carbenicillin or ampicillin. Since the indanyl ester function changes carbenicillin from a very polar compound to a more lipophilic penicillin, the hydrophobic character of indanyl penicillin may assist in its transport through the gram-positive cell wall to the penicillin-sensitive site, the transpeptidase enzyme (4, 10) . Such facilitated transport is reflected in the MIC values of 0.05 to 0.08 for carbenicillin indanyl sodium compared to 0.3 to 0.8 for carbenicillin with S. aureus Oxford. This interpretation is in complete agreement with results obtained by Biagi and co-workers using chromatographic techniques (2) . They found that the more lipophilic penicillins and cephalosporins have better activity against gram-positive bacteria. Both carbenicillin indanyl sodium and carbenicillin were considerably more active in vitro against penicillinase-producing isolates of S. aureus than was ampicillin. As presented in Table 1 , the median MIC of ampicillin for these isolates was 200 Ag/ml.
The general equivalency of carbenicillin in- (Tables 3 and 4 ). As presented in Table  3 , carbenicillin indanyl sodium and carbenicillin appear to have equivalent activity against clinical Pseudomonas isolates. Carbenicillin indanyl sodium, carbenicillin disodium, and ampicillin had very similar activity against recent P. mirabilis and E. coli isolates (Table 4) . However, both carbenicillin indanyl sodium and carbenicillin were superior to ampicillin against strains of P. vulgaris and other indole-positive Proteus species (Table 4) . Carbenicillin indanyl sodium is markedly more stable to an acidic environment than is carbenicillin disodium. Exposure of carbenicillin indanyl sodium to pH 2.0 (in a synthetic gastric juice) for 1 hr at 37 C resulted in no detectable loss of biological activity ( The PD50 values of carbenicillin indanyl sodium administered orally or subcutaneously were nearly identical against the various experimental infections presented in Table 6 . In addition, the oral PD50 values of carbenicillin indanyl sodium against the experimental infections presented in Tables 6 and 7 were comparable to those of parenteral carbenicillin and further demonstrate that the ester form of carbenicillin is an orally effective form of carbenicillin.
The activity of carbenicilhin indanyl sodium against experimental urinary-tract infections in rats is presented in Tables 8 and 9 . Table 8 shows the activity of the six drugs used in our studies against E. coli as the infecting organism. The counts of viable organisms per gram of kidney tissue for the infected controls are consistently high, ranging from an organism count of log 6.76 to log 8.20. Carbenicillin indanyl sodium was as active as the other antibioticd studied, when tested at the same levels. Cephaloglycin, unexpectedly, did not perform well when administered orally at relatively high doses. Several additional trials with oral cephaloglycin at these levels have been consistent with the values presented. Parenterally administered cephaloglycin is, however, significantly active against E. coli urinary-tract infections in the rat.
As shown in Table 9 , carbenicillin indanyl sodium, carbenicillin, and nitrofurantoin are generally able to reduce significantly the count of viable P. vulgaris cells in the rat kidney at the dosages evaluated. Again, the activity of carbenicillin indanyl sodium is quite similar to that of carbenicillin. Neither ampicillin nor nitrofurantoin at 100 mg/kg was able to reduce the count of viable P. aeruginosa cells in the kidney tissue. Carbenicillin indanyl sodium and carbenicilhin at the two higher levels effected a significant response. At 50 mg/kg, both carbenicillin and its ester exhibit marginal activity.
